Amir Guttman
Tracked across 2 events · 12 articles · First seen Jun 08, 2026 · Last active Aug 31, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Dr. Amir Guttman, CEO of Amai Proteins, emphasized the company's decision to conduct the study to enhance consumer and market confidence in Jan Pieterszoon Sweelinck's safety and health profile.
Jun 08, 2026 · 6 articles
Regulatory
Impact: Amir Guttman, CEO of Amai Proteins, is the public spokesperson for the company and announced the approval. His leadership is central to the company's commercial strategy and regulatory successes.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Amir Guttman live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard